Epitranscriptomic RNA m6A Modification in Cancer Therapy Resistance: Challenges and Unrealized Opportunities
Abstract Significant advances in the development of new cancer therapies have given rise to multiple novel therapeutic options in chemotherapy, radiotherapy, immunotherapy, and targeted therapies. Although the development of resistance is often reported along with temporary disease remission, there...
Saved in:
Main Authors: | Mohammad Burhan Uddin, Zhishan Wang, Chengfeng Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Advanced Science |
Subjects: | |
Online Access: | https://doi.org/10.1002/advs.202403936 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The interplay between RNA m6A modification and radiation biology of cancerous and non-cancerous tissues: a narrative review
by: Yajia Cheng, et al.
Published: (2024-12-01) -
Inhibition of METTL14 overcomes CDK4/6 inhibitor resistance driven by METTL14-m6A-E2F1-axis in ERα-positive breast cancer
by: Chenlin Liu, et al.
Published: (2025-01-01) -
Methyltransferase-like 7B participates in bladder cancer via ACSL3 m6A modification in a ferroptosis manner
by: Jiani He, et al.
Published: (2025-01-01) -
The therapeutic potential of RNA m(6)A in lung cancer
by: Jingran Yu, et al.
Published: (2024-12-01) -
Exploring RNA modifications in infectious non-coding circular RNAs
by: Pavel Vopalensky, et al.
Published: (2025-02-01)